Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in MyoCardial Infarction (AMICI)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Teva Pharmaceuticals USA

Information provided by (Responsible Party):

Mesoblast, Ltd.

ClinicalTrials.gov Identifier:

NCT01781390

First received: January 14, 2013

Last updated: September 13, 2016

Last verified: September 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2018
Estimated Primary Completion Date:	January 2017 (Final data collection date for primary outcome measure)